Feng Jin

3.7k total citations
58 papers, 1.0k citations indexed

About

Feng Jin is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Feng Jin has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 12 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Feng Jin's work include Chronic Lymphocytic Leukemia Research (15 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Feng Jin is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Feng Jin collaborates with scholars based in China, United States and Ghana. Feng Jin's co-authors include Joseph P. Balthasar, Saileta Prabhu, Suhasini Iyer, Rong Deng, Srini Ramanathan, Debao Liu, Minfang Chen, Huafeng Zhou, Brian P. Kearney and Wojciech Krzyżański and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Feng Jin

56 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Jin China 18 296 205 172 152 151 58 1.0k
Xiaoye Zhou China 16 360 1.2× 183 0.9× 248 1.4× 234 1.5× 281 1.9× 33 1.3k
Martin Dietrich United States 16 647 2.2× 112 0.5× 442 2.6× 399 2.6× 46 0.3× 41 1.5k
Yining Yang China 18 436 1.5× 93 0.5× 63 0.4× 138 0.9× 32 0.2× 70 1.1k
Hong Shan China 20 232 0.8× 44 0.2× 69 0.4× 114 0.8× 34 0.2× 70 1.2k
Xiaoqun Li China 22 979 3.3× 104 0.5× 68 0.4× 252 1.7× 49 0.3× 64 1.6k
Hongwei Peng China 19 285 1.0× 140 0.7× 67 0.4× 132 0.9× 115 0.8× 66 927
Huilai Zhang China 23 581 2.0× 365 1.8× 300 1.7× 727 4.8× 685 4.5× 159 1.8k
Vincent Lemaire United States 8 300 1.0× 144 0.7× 48 0.3× 333 2.2× 34 0.2× 11 882
Neena Kalia United Kingdom 22 397 1.3× 371 1.8× 265 1.5× 136 0.9× 99 0.7× 67 1.6k
George Z. Cheng United States 24 1.4k 4.8× 178 0.9× 140 0.8× 750 4.9× 199 1.3× 67 2.6k

Countries citing papers authored by Feng Jin

Since Specialization
Citations

This map shows the geographic impact of Feng Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Jin more than expected).

Fields of papers citing papers by Feng Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Jin. The network helps show where Feng Jin may publish in the future.

Co-authorship network of co-authors of Feng Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Jin. A scholar is included among the top collaborators of Feng Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Jin. Feng Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Yuxia, Huiqin Zhang, Gang Yang, et al.. (2025). The correlation between the polymorphism of lysolecithin acyltransferase (MBOAT7) rs641738 and liver fibrosis. Personalized Medicine. 22(2). 113–119. 1 indexed citations
3.
Jin, Feng, et al.. (2025). Clinical significance of risk factor analysis in pancreatic cancer by using supervised model of machine learning. Frontiers in Medicine. 12. 1551926–1551926.
4.
5.
Funt, Samuel A., Petros Grivas, Xīn Gào, et al.. (2024). Evorpacept plus enfortumab vedotin in patients (Pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Phase 1a dose escalation results.. Journal of Clinical Oncology. 42(16_suppl). 4575–4575. 1 indexed citations
6.
Niu, Li, et al.. (2024). Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(5). 189125–189125. 1 indexed citations
7.
Gao, Liwei, Ye Liu, Bo Chen, et al.. (2023). Metformin plays an antitumor role by downregulating inhibitory cells and immune checkpoint molecules while activating protective immune responses in breast cancer. International Immunopharmacology. 118. 110038–110038. 10 indexed citations
8.
9.
Zhang, Meilin, et al.. (2022). Breast adenoid cystic carcinoma: a report of seven cases and literature review. BMC Surgery. 22(1). 113–113. 8 indexed citations
10.
Wang, Cheng, et al.. (2022). Outcomes of surgery for different types of chronic pulmonary aspergillosis: results from a single-center, retrospective cohort study. BMC Pulmonary Medicine. 22(1). 40–40. 10 indexed citations
11.
12.
Li, Wei, et al.. (2021). Astragaloside IV Prevents Memory Impairment in D-galactose-induced Aging Rats Via the AGEs/RAGE/ NF-κB Axis. Archives of Medical Research. 53(1). 20–28. 18 indexed citations
13.
Xiu, Lei, Xiaohong Hu, Zhang Tin, et al.. (2020). HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression. Cellular Signalling. 72. 109631–109631. 30 indexed citations
14.
Li, Zhengquan, Dong Guo, Zhen Zhang, et al.. (2020). Brain Metastases of Non-Small Cell Lung Cancer: Magnetic Resonance Spectroscopy for Clinical Outcome Assessment in Patients with Stereotactic Radiotherapy. OncoTargets and Therapy. Volume 13. 13087–13096. 7 indexed citations
15.
Ramanathan, Srini, et al.. (2016). Pharmacokinetics, Pharmacodynamics, and Safety of Entospletinib, a Novel pSYK Inhibitor, Following Single and Multiple Oral Dosing in Healthy Volunteers. Clinical Drug Investigation. 37(2). 195–205. 19 indexed citations
16.
Han, Yunan, Qingfu Zhang, Xinmiao Yu, et al.. (2015). Immunohistochemical detection of STAT6, CD34, CD99 and BCL-2 for diagnosing solitary fibrous tumors/hemangiopericytomas.. PubMed Central. 8(10). 13166–75. 49 indexed citations
17.
Jin, Feng, et al.. (2013). The Pharmacokinetics and Safety Of Idelalisib In Subjects With Severe Renal Impairment. Blood. 122(21). 5572–5572. 6 indexed citations
18.
Wang, Bing, Meina Liang, Zhenling Yao, et al.. (2012). Pharmacokinetic and Pharmacodynamic Comparability Study of Moxetumomab Pasudotox, an Immunotoxin Targeting CD22, in Cynomolgus Monkeys. Journal of Pharmaceutical Sciences. 102(1). 250–261. 8 indexed citations
19.
Lin, Patrick P., et al.. (2009). Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice. Carcinogenesis. 30(10). 1789–1795. 92 indexed citations
20.
Jin, Feng, et al.. (2005). Pharmacokinetic and pharmacodynamic effects of high-dose monoclonal antibody therapy in a rat model of immune thrombocytopenia. The AAPS Journal. 7(4). E895–E902. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoye Zhou Breakdown of academic impact, for papers by Martin Dietrich Breakdown of academic impact, for papers by Yining Yang Breakdown of academic impact, for papers by Hong Shan Breakdown of academic impact, for papers by Xiaoqun Li Breakdown of academic impact, for papers by Hongwei Peng Breakdown of academic impact, for papers by Huilai Zhang Breakdown of academic impact, for papers by Vincent Lemaire Breakdown of academic impact, for papers by Neena Kalia Breakdown of academic impact, for papers by George Z. Cheng
Rankless by CCL
2026